Literature DB >> 12642236

Inflammatory hypersensitivity in a rat model of trigeminal neuropathic pain.

Leigh C Anderson1, Alexander Vakoula, Ruth Veinote.   

Abstract

Thermal and mechanical stimuli have been used to monitor the development of neuropathic pain following an experimental injury to a branch of the trigeminal nerve. However, the response to inflammatory challenge has not been evaluated in a model of orofacial neuropathic pain. The purpose of this study was to determine whether chronic constriction of the infraorbital nerve (IoN) enhances nociceptive responses elicited by the formalin test. The characteristic biphasic response (primarily directed grooming) to formalin injected subcutaneously in the right vibrissae pad was observed in sham-injury rats. Twenty-one days after IoN constriction, formalin injection provoked an immediate response that involved both directed grooming and other abnormal behaviors, e.g. flinching, trismus and shielding of the affected region. As with sham-injury rats, this was followed by a quiescent period and then a second phase of nocifensive behaviors. The total time recorded for all pain-related behaviors was significantly greater in rats with constrictive injuries (P<0.001), due primarily to the exhibition of novel pain-related responses. Histological examination (qualitative) revealed that chronic constriction resulted in a ligature-induced neuroma, as well as a partial denervation of the affected sensory field. Thus, an intense inflammatory hypersensitivity in a rat model of orofacial neuropathic pain develops in association with partial denervation and with an ongoing perineural inflammatory response and neuroma formation.

Entities:  

Mesh:

Year:  2003        PMID: 12642236     DOI: 10.1016/s0003-9969(02)00203-0

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  8 in total

1.  Analgesic effect of diprospan in rats with trigeminal neuralgia.

Authors:  Yanxiu Wang; Xiaoguang Li; Lingmin Cao; Yuke Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

2.  Focal Inflammation Causes Carbenoxolone-Sensitive Tactile Hypersensitivity in Mice.

Authors:  Regina Hanstein; Julie B Zhao; Rajshekhar Basak; David N Smith; Yonatan Y Zuckerman; Menachem Hanani; David C Spray; Maria Gulinello
Journal:  Open Pain J       Date:  2010-01-01

3.  Partial infraorbital nerve ligation as a model of trigeminal nerve injury in the mouse: behavioral, neural, and glial reactions.

Authors:  Mei Xu; Megumi Aita; Charles Chavkin
Journal:  J Pain       Date:  2008-08-16       Impact factor: 5.820

4.  Spared nerve injury model to study orofacial pain.

Authors:  Daniel Humberto Pozza; José Manuel Castro-Lopes; Fani Lourenca Neto; António Avelino
Journal:  Indian J Med Res       Date:  2016-03       Impact factor: 2.375

Review 5.  Neuron-Glia Crosstalk and Neuropathic Pain: Involvement in the Modulation of Motor Activity in the Orofacial Region.

Authors:  Mohammad Zakir Hossain; Shumpei Unno; Hiroshi Ando; Yuji Masuda; Junichi Kitagawa
Journal:  Int J Mol Sci       Date:  2017-09-26       Impact factor: 5.923

6.  Autologous conditioned serum (Orthokine) injection for treatment of classical trigeminal neuralgia: results of a single-center case series.

Authors:  Dawood Aghamohammadi; Shahrzad Sharifi; Seyed Kazem Shakouri; Yashar Eslampour; Neda Dolatkhah
Journal:  J Med Case Rep       Date:  2022-05-08

7.  Effects of removal of dietary polyunsaturated fatty acids on plasma extravasation and mechanical allodynia in a trigeminal neuropathic pain model.

Authors:  Yasmina B Martin; Carlos Avendaño
Journal:  Mol Pain       Date:  2009-02-25       Impact factor: 3.395

8.  Single-Dose P2 X4R Single-Chain Fragment Variable Antibody Permanently Reverses Chronic Pain in Male Mice.

Authors:  Karin N Westlund; Marena A Montera; Aleyah E Goins; Sascha R A Alles; Nikita Suri; Sabrina L McIlwrath; Robyn Bartel; Ravi V Durvasula; Adinarayana Kunamneni
Journal:  Int J Mol Sci       Date:  2021-12-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.